Olive Leaf has Blood Pressure Lowering Effect

A clinical trial carried out in Germany with twins has confirmed the blood pressure reducing effect of Frutarom’s Olive Leaf special extract, EFLA 943.

08/11/05 EFLA 943 Frutarom’s special olive leaf extract is the first herbal extract whose blood pressure reducing benefits has been proven in a clinical trial. The trial, carried out in Germany across a period of 8 weeks, involved monozygotic twins with slightly higher blood pressure receiving a daily dose of 500 – 1,000mg of EFLA 943. The results confirmed a dosage-dependent blood pressure reduction, with maximum values amounting to decreases by 19 mmHg systolic and 10 mmHg diastolic respectively. The study also proved there was the additional benefit of LDL cholesterol reduction. Moreover, the strongly anti-oxidative olive leaf special extract showed no evidence of side effects and tolerance was extremely high.

The confirmation of the blood pressure reducing effect for patients is of great significance with regard to the use of this natural herbal extract and opens new doors for manufacturers of phytopharmaceutics, food additives, and functional foods as well as offering great potential for designing new, innovative products.

Natural products with confirmed health benefits and high quality meet today’s market expectations perfectly. In order to satisfy customers’ specific requirements, Frutarom continuously invests in the development of new and innovative products providing additional benefits to its customers in both the pharma and food industries.

EFLA 943 Olive Leaf Special Extract ensures highest quality and greatest safety. According to ICH guidelines, the extract was tested for stability, standardized to oleuropein, produced in line with a validated and patented production procedures and in compliance with GMP (Good Manufacturing Practice) as well as ISO guidelines. Furthermore, Frutarom’s own HyperPure procedure guarantees the removal of any possible pesticide residues.